While certain elements of clinical trial decentralisation existed before the COVID-19 pandemic, they were not commonly used across trials. The pandemic forced the research industry to adopt and deliver decentralised clinical trials, with 80% of CROs predicting that they will conduct decentralised trials by 2021-2022 (EndpointsNews Survey, May 2021). This transition was driven by the need for urgent public health trials to quickly find treatments and vaccines for COVID-19, where delivering trial procedures remotely to participants became a necessity.

Heard of dogfooding? No, not feeding your pet! The practice of using your own software to understand how it performs in the real world and catch any issues. Read about this and other software engineering hacks we are using to build better products.

Digital Therapeutics are still a relatively new treatment area and there is a lot to learn about conducting clinical research on them. Find out how Paul Wick's, Digital Health expert, thinks research companies can put the patients first.

Lindus Health's objective is to build better products that hit non-negotiable clinical standards and challenge outdated conventions. How do we do this? Read more here

Working towards a good cause. Innovative approaches to solving problems in clinical trial design. Every contribution is valued.

Don't be put off by the blunt use of the word "boring" to describe our technology. It's one of our guiding principles allowing us to make rapid progress while maintaining high quality standards. Read more here.